Todoset 600 (Etodolac ER) Tablets: PCD Franchise & Third Party Manufacturing With Servochem

Todoset 600 is Servochem's extended-release Etodolac 600mg formulation, built specifically for long-term management of osteoarthritis and rheumatoid arthritis — not acute pain. That distinction matters more than it might seem, and it's the actual reason the ER format exists in the first place.

Why Extended-Release, Specifically

Conventional (immediate-release) Etodolac is typically dosed 2 to 4 times a day to maintain therapeutic effect. The extended-release format changes that: it's designed for once-daily administration, maintaining sustained drug levels instead of the peaks and troughs of multiple daily doses. For patients managing chronic joint conditions over months or years, fewer daily doses generally means better treatment adherence — a real clinical rationale, not a marketing angle.

One important accuracy point worth knowing if you're representing this product to prescribers: extended-release etodolac tablets are not recommended for managing acute pain — the format is built for sustained, long-term therapy in chronic conditions, not short-term flare-ups. Positioning it correctly with prescribers avoids a mismatch between what the product is designed for and what it gets used for.

How Todoset 600 Fits Alongside Servochem's Other NSAIDs

If you're building a broader ortho portfolio, it's worth understanding how Todoset 600 differs pharmacologically from Servochem's other pain-management products. Etodolac is classified as a reversible COX-1/COX-2 inhibitor — a different mechanism than Servochem's Koxitor range (Etoricoxib), which is a more selective COX-2 inhibitor. In practice, this means the two products tend to serve different prescribing preferences: Koxitor for cases where GI tolerability from more selective COX-2 inhibition is the priority, and Todoset 600 as an established, well-characterized NSAID option with a long clinical track record. Carrying both gives franchise partners genuine prescriber-preference coverage rather than two products competing for the exact same use case.

Specifications

Indicated for: Osteoarthritis, rheumatoid arthritis, chronic musculoskeletal pain, inflammatory joint disorders, and long-term inflammatory conditions requiring sustained therapy.

Available as PCD Pharma Franchise

Partner with Servochem to market and distribute Todoset 600 under an agreed area, backed by:

• WHO-GMP certified manufacturing with documented batch-level quality checks
• Consistent order fulfillment and dispatch
• Product literature and promotional material ready to use directly with doctors and chemists

Available as Third Party Manufacturing

If you're building your own brand, Servochem manufactures Etodolac 600mg ER under your label through its third party manufacturing service — formulation, production, and quality testing handled in-house, so you can focus on marketing and distribution under your own name.

A Note on NSAID Class Warnings

Like all NSAIDs, Etodolac carries standard class-wide cautions around cardiovascular and gastrointestinal risk with long-term use, and is contraindicated around certain surgical settings. If you're producing your own marketing or product literature around Todoset 600, it's worth referencing full prescribing information rather than summarizing safety details independently — this keeps materials accurate and compliant.

How to Get Started

Whether you're evaluating a PCD franchise partnership or need a third-party manufacturer for your own Etodolac ER brand, pricing, MOQs, and area availability are handled directly through the enquiry form on the Todoset 600 product page.

Frequently Asked Questions

Why is Todoset 600 dosed once daily instead of multiple times a day?

The extended-release formulation is designed to release Etodolac gradually, maintaining sustained drug levels with a single daily dose — compared to conventional Etodolac, which is typically dosed 2 to 4 times a day. This generally supports better treatment adherence in long-term therapy.

Is Todoset 600 suitable for acute pain?

No. Extended-release Etodolac tablets are built for sustained, long-term management of chronic conditions like osteoarthritis and rheumatoid arthritis, not for acute or short-term pain relief.

How is Todoset 600 different from Servochem's Koxitor range?

Etodolac (Todoset 600) is a reversible COX-1/COX-2 inhibitor, while Koxitor (Etoricoxib) is a more selective COX-2 inhibitor. The two suit different prescriber preferences rather than competing for the same use case, which is why many franchise partners carry both.

What's the difference between PCD franchise and third party manufacturing for this product?

Under PCD franchise, you market and distribute Todoset 600 under Servochem's own brand within an agreed area. Under third party manufacturing, Servochem manufactures Etodolac 600mg ER under your own brand label instead.

Is Todoset 600 manufactured under WHO-GMP conditions?

Yes. Every batch is manufactured under WHO-GMP certified conditions with documented quality checks at each stage of production.

How do I get pricing and area availability for Todoset 600?

Submit an enquiry directly through the Todoset 600 product page, specifying whether you're interested in PCD franchise or third party manufacturing, along with your target operating area.